Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Buy
+12,930
New +$250K ﹤0.01% 2750
2025
Q4
Sell
-13,482
Closed -$253K 3037
2025
Q3
$253K Buy
+13,482
New +$242K ﹤0.01% 2394
2024
Q3
Sell
-14,108
Closed -$248K 2605
2024
Q2
$248K Buy
14,108
+603
+4% +$12.5K ﹤0.01% 1918
2024
Q1
$347K Buy
+13,505
New +$339K ﹤0.01% 1786
2022
Q2
Sell
-7,821
Closed -$235K 1249
2022
Q1
$235K Buy
+7,821
New +$244K ﹤0.01% 817

Other funds holding XP

Cerity Partners's XP Position: Q1 2026 in Review

Cerity Partners opened a new position in XP (XP) in Q1 2026: 12,930 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #2750 among its holdings. This is a return to the name: Cerity Partners previously reported a position in XP as recently as Q3 2025.

Cerity Partners first reported a position in XP in Q1 2022 and has held it in 5 quarters since. The position peaked at $347K in Q1 2024. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Cerity Partners held 12,930 shares of XP worth $246K as of Q1 2026.
  • XP was a new Cerity Partners position in Q1 2026.
  • XP made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2750 holding.
  • Cerity Partners first reported a position in XP in Q1 2022 and has held it in 5 quarters since.
  • Cerity Partners's XP position peaked at $347K in Q1 2024.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.